You want to advance new therapies, the right way. And time is money. We can help.

With a recent explosion in the industry, and pipeline set for decades to come, we understand that time is essential for gene and cell therapy drug development where IBC and IRB review is required. With our integrated niche service, working together, Castle IRB and Clinical Biosafety (IBC) Services reduce regulatory inconsistencies (read: delays) for sponsors and CROs and offer unparalleled communication through study start-up.

We speak Biotech. Request a quote for your clinical trial today!